immune system
• at 12 weeks of age in 15.68% of mice
|
• increase in the proportion of CD71+ erythroid cells in the spleen of diseased mice
|
• IgG deposits in the glomeruli and damaged skins
|
• CD71+ erythroid cells in the spleen produce elevated reactive oxygen species
• co-culture of CD71+ erythroid cells and lymphocytes results in increased levels of double strand DNA and IgG in the supernatant suggesting that the erythroid cells lead to activation of lymphocytes
|
• increased 2.38 fold
|
• increased 3.91 fold
|
• with mesangial hyperplasia
|
integument
skin lesions
(
J:351618
)
• with sebaceous hyperplasia and massive lymphocyte infiltration
|
• at 12 weeks of age in 15.68% of mice
|
hematopoietic system
• at 12 weeks of age in 15.68% of mice
|
• increase in the proportion of CD71+Ter119- and CD71+Ter119+ cells in the spleen at 20 weeks of age compared to controls indicating a inhibition in the differentiation and development of erythroid cells
|
• increase in the proportion of CD71+ erythroid cells in the spleen of diseased mice
|
• IgG deposits in the glomeruli and damaged skins
|
• CD71+ erythroid cells in the spleen produce elevated reactive oxygen species
• co-culture of CD71+ erythroid cells and lymphocytes results in increased levels of double strand DNA and IgG in the supernatant suggesting that the erythroid cells lead to activation of lymphocytes
|
renal/urinary system
• with mesangial hyperplasia
|
growth/size/body
• at 12 weeks of age in 15.68% of mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
systemic lupus erythematosus | DOID:9074 |
OMIM:152700 OMIM:300809 OMIM:605480 OMIM:608437 OMIM:609903 OMIM:609939 OMIM:610065 OMIM:610066 OMIM:612254 OMIM:612378 OMIM:613145 OMIM:614420 |
J:351618 |